M&R Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

M&R Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-840	Closed	-$141K	–	413
2020 Q4	$141K	Hold	840	–	–	0.03%	175
2020 Q3	$132K	Hold	840	–	–	0.03%	174
2020 Q2	$140K	Hold	840	–	–	0.04%	170
2020 Q1	$110K	Hold	840	–	–	0.03%	187
2019 Q4	$124K	Hold	840	–	–	0.03%	199
2019 Q3	$103K	Hold	840	–	–	0.02%	210
2019 Q2	$118K	Hold	840	–	–	0.03%	205
2019 Q1	$117K	Buy	840 +250	+42%	+$36K	0.03%	209
2018 Q4	$73K	Hold	590	–	–	0.02%	228
2018 Q3	$93K	Hold	590	–	–	0.02%	233
2018 Q2	$82K	Hold	590	–	–	0.02%	243
2018 Q1	$78K	Hold	590	–	–	0.02%	250
2017 Q4	$73K	Buy	590 +200	+51%	+$24.7K	0.02%	267
2017 Q3	$48K	Hold	390	–	–	0.01%	305
2017 Q2	$44K	Hold	390	–	–	0.01%	314
2017 Q1	$41K	Buy	390 +60	+18%	+$6.01K	0.01%	319
2016 Q4	$29K	Buy	+330	New	+$30.9K	0.01%	331

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

M&R Capital Management's FBT Position: Q1 2021 in Review

M&R Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2021, closing a stake of 840 shares — an estimated $141K sold.

M&R Capital Management first reported a position in FBT in Q4 2016 and held it in 17 quarters. The position peaked at $141K in Q4 2020. 236 funds tracked by Wall St. Rank hold FBT as of Q1 2021.

M&R Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2021 after selling out during the quarter.
M&R Capital Management sold 840 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2021, an estimated $141K.
M&R Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2016 and held it in 17 quarters.
M&R Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $141K in Q4 2020.
236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2021.

Based on M&R Capital Management's 13F filing for Q1 2021, filed 1 Apr 2021.